John D Delaney

Address:

3215 Arden Cir, Melbourne, FL 32934

VIN:

1GNDV33157D161558

Make:

CHEVROLET

Model:

UPLANDER

Year:

2007

US Patent:

41634845, Aug 7, 1979

Filed:

Apr 18, 1978

Appl. No.:

5/897563

Inventors:

John H. Delaney - Whitestone NY

International Classification:

A45C 1336

US Classification:

190 18R

Abstract:

A member having a flat base and a raised resilient body adapted to be manufactured and produced in many colors and designs, including means for quick adhesive attachment of a flat base portion thereof to luggage along edges or around corners which may be subjected to rough usage, the member serving in the dual capacity of protector and as a means for permitting the owner to identify his luggage quickly.

US Patent:

42225965, Sep 16, 1980

Filed:

Jul 13, 1978

Appl. No.:

5/924179

Inventors:

John H. Delaney - Whitestone NY

International Classification:

E05C 304

US Classification:

292342

Abstract:

A ventilation stop mounted on a side rail of the upper sash of a double-hung window, capable of being swung into and out of the path of the upper horizontal rail of the lower sash to permit only limited relative opening movement of the upper and lower sashes.

US Patent:

48528323, Aug 1, 1989

Filed:

Aug 31, 1988

Appl. No.:

7/239053

Inventors:

John H. Delaney - Whitestone NY

International Classification:

F16L 308

US Classification:

248 65

Abstract:

There is disclosed a novel decorative light holder which includes means for retaining separate lights and intermediate wiring along straight and curvilinear paths including paths perpendicular to each other; and includes contact adhesive means to permit easy attachment on walls or other structures, such as window frames or adjacent interior or exterior wall structures.

US Patent:

41039475, Aug 1, 1978

Filed:

Feb 4, 1977

Appl. No.:

5/765632

Inventors:

John H. Delaney - Whitestone NY

International Classification:

E05C 302

US Classification:

292194

Abstract:

A ventilation stop mounted on a side rail of the upper sash of a double-hung window, capable of being swung into and out of the path of the upper horizontal rail of the lower sash to permit only limited relative opening movement of the upper and lower sashes.

US Patent:

42649560, Apr 28, 1981

Filed:

Nov 28, 1979

Appl. No.:

6/098267

Inventors:

John M. Delaney - Wayne NJ

International Classification:

G06F 1521

US Classification:

364467

Abstract:

A telephone call cost monitor to enable the user of a telephone to monitor accurately the cost of his outgoing phone calls while those calls are in progress. The device includes a programmable memory, a micro-computer, a keyboard for data entry, a pickup coil to sense signals on the telephone line, an internal timer, a digital clock display, and start and stop keys. The device enables a user to preprogram at his convenience the telephone numbers he calls and the various tariffs for these calls. Thus, when the user wishes to monitor the cost of a call, he only needs to push the start key when actual connection is made with the called telephone. The cost of the call is continuously displayed and at the completion of the call the user only has to push a reset button to prepare the device for the next call.

US Patent:

20150284471, Oct 8, 2015

Filed:

Dec 7, 2012

Appl. No.:

14/363777

Inventors:

- Thousand Oaks CA, US
Michael Wittekind - New Canaan CT, US
John M. Delaney - Bellevue WA, US
Mingyue Zhou - Union City CA, US
Derek E. Piper - Santa Clara CA, US

International Classification:

C07K 16/40
A61K 45/06
A61K 39/395

Abstract:

Antigen binding proteins that activate LCAT are provided. Nucleic acids encoding the antigen binding proteins and vectors and cells containing such nucleic acids are also provided. The antigen binding proteins have value in therapeutic methods in which it is useful to modulate HDL particle size, increase plasma levels of HDL-C, and increase reverse cholesterol transport. Accordingly, the antigen binding proteins have utility in the treatment and prevention of atherosclerosis, various cardiovascular diseases and cholesterol-related disorders, inflammatory conditions, thrombosis-related conditions, metabolic syndrome, diabetes and insulin-resistance. The LCAT antigen binding proteins are also useful in treating the consequences, symptoms, and/or pathology associated with either genetic or acquired LCAT deficiency, including chronic kidney disease (CKD).